Ritholtz Wealth Management Acquires New Stake in iShares Biotechnology ETF $IBB

Ritholtz Wealth Management acquired a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 3,939 shares of the financial services provider’s stock, valued at approximately $665,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC bought a new position in iShares Biotechnology ETF during the 2nd quarter valued at approximately $25,000. Ashton Thomas Securities LLC bought a new position in iShares Biotechnology ETF during the 3rd quarter valued at approximately $36,000. Parkside Financial Bank & Trust increased its position in iShares Biotechnology ETF by 48.6% during the 3rd quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after buying an additional 87 shares in the last quarter. Close Asset Management Ltd increased its position in iShares Biotechnology ETF by 25.5% during the 3rd quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after buying an additional 70 shares in the last quarter. Finally, Founders Financial Alliance LLC increased its position in iShares Biotechnology ETF by 605.7% during the 3rd quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock valued at $54,000 after buying an additional 321 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.1%

IBB stock opened at $175.99 on Thursday. iShares Biotechnology ETF has a twelve month low of $116.25 and a twelve month high of $179.64. The business has a 50 day moving average of $170.17 and a 200 day moving average of $166.81.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were given a dividend of $0.1218 per share. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.